Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. We did a randomized, parallel, open-label, pragmatic trial in 33 academic and non-academic Italian hospitals.
